Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...
Researchers in the Pancreatic Cancer Early Detection Research Program are using multiple approaches to develop new tools for the early detection of pancreatic cancer, collaborating not only within our ...
Mayo Clinic cares for nearly 1,100 people with pancreatic cancer each year. In addition, the High-Risk Pancreas Clinic offers people at high risk of developing pancreatic cancer an evaluation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback